Glenmark Pharmaceuticals has announced the launch of Vancomycin Hydrochloride for Injection USP in the U.S. market, expanding its injectable portfolio amid growing demand for affordable hospital medicines. The company said the product will be available in 500 mg/vial and 1 g/vial strengths through its U.S.-based arm, Glenmark Pharmaceuticals Inc., USA. Targets $37.9 million market opportunity […]